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Research article
Lanthanide(III) complexes are more active
inhibitors of the Fenton reaction than pure
ligands
Jan Martin1, Prˇemysl Mladeˇnka2, Luciano Saso3, Irena Kostova4
1Department of Pharmacognosy, Faculty of Pharmacy in Hradec Králové, Charles University in Prague,
Heyrovského 1203, 500 05, Czech Republic, 2Department of Pharmacology and Toxicology, Faculty of Pharmacy
in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05, Czech Republic, 3Department of
Physiology and Pharmacology ‘Vittorio Erspamer’, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185,
Italy, 4Department of Chemistry, Faculty of Pharmacy, Medical University, 2 Dunav Street, Sofia 1000, Bulgaria
Objectives: This study is an extension to our finding of direct anti-oxidant activities of lanthanide(III)
complexes with the heterocyclic compound, 5-aminoorotic acid (AOA). In this experiment, we used AOA
and coumarin-3-carboxylic acid as the two heterocyclic compounds with anti-oxidant potential, to produce
the complexes with different lanthanides.
Methods: Lanthanide(III) complexes were tested on the iron-driven Fenton reaction. The product of this
reaction, the hydroxyl radical, was detected by HPLC.
Results: All complexes as well as their ligands had positive or neutral effect on the Fenton reaction but their
behavior was different. Both pure ligands in low concentration ratio to iron were inefficient in contrast to some
of their complexes. Complexes of neodymium, samarium, gadolinium, and partly of cerium blocked the
Fenton reaction at very low ratios (in relation to iron) but the effect disappeared at higher ratios. In
contrast, lanthanum complexes appeared to be the most promising. Both blocked the Fenton reaction in a
dose-dependent manner.
Conclusion: Lanthanide(III) complexes were proven to block the iron-driven production of the hydroxyl
radical. Second, the lanthanide(III) element appears to be crucial for the anti-oxidant effect. Overall,
lanthanum complexes may be promising direct anti-oxidants for future testing.
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Introduction
Anti-oxidants have the ability to protect cellular orga-
nelles from free radical oxidative damage but the
majority can act as pro-oxidants as well, apparently
due their high reducing capacity.1–3 Such behavior
can also be found in anti-oxidant compounds with
low or moderate iron-binding capacity.2 These com-
pounds can behave very differently depending on
their ratio to iron, due to mixed effects, e.g. direct
scavenging of free radicals like the hydroxyl radical,
iron reduction, and chelation. For this reason, a
given compound can be pro- and anti-oxidant depend-
ing on other conditions.
The lanthanides have not been largely examined
from biological point of view but it appears to
possess some interesting pharmacological activities.
It needs no discussion that the lanthanides have been
investigated and widely described from the chemical
viewpoint and they provide fascinating new possibili-
ties for research in the coming decades. Their great
potential derives in part from their intrinsic anti-
oxidant properties.4,5 Lanthanide inhibition of reac-
tive oxygen species (ROS) propagation involves the
strong oxyphilicity inherent in the lanthanides. The
availability of oxygen sites on these free radicals
makes them excellent targets for Ln(III) coordination.
In addition to the lanthanides, various heterocyclic
compounds also have anti-oxidant properties. This
study forms a continuation of our interest in the
coordination chemistry of the heterocyclic compounds
and their lanthanide(III) complexes.
One heterocyclic compound, orotic acid, an inter-
mediate in pyrimidine biosynthesis, and its derivatives
are promising as future drugs.6,7 One of these
Correspondence to: Prˇemysl Mladeˇnka, Department of Pharmacology and
Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in
Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
Email: mladenkap@faf.cuni.cz
© 2016 Informa UK Limited, trading as Taylor & Francis Group
DOI 10.1179/1351000215Y.0000000031 Redox Report 2016 VOL. 21 NO. 284
derivatives, 5-aminoorotic acid (AOA, Fig. 1) which
has relatively unknown coordination chemistry, was
analyzed in this study.
Coumarins are very widely distributed in nature and
some have proven anti-bacterial,8 anti-fungal,9 anti-
inflammatory,10 anti-coagulant,11 anti-HIV,12,13 and
anti-tumor activity.14–19 The ability of coumarins to
bind metal ions represents20 an additional mean of
modulating their pharmacological responses. It has
been found that the binding of a metal to the coumarin
moiety retains or enhances its biological activity.15–17
The position and the type of the substituent attached
to the aromatic ring of coumarin molecules have a pro-
nounced influence on the anti-oxidant activity of these
compounds.21
In a series of papers, we investigated the molecular
structure, energetic, and spectroscopic properties of
different coumarin derivatives and their lanthanide
complexes, as well as their pharmacological
activity.15–17,22–26 These studies highlighted the poten-
tial for developing novel lanthanide complexes mainly
as anti-cancer therapeutics. However, more analogs
are required to obtain better activity profiles for this
class of compounds.
This study is an extension of our earlier publications
on the synthesis of metal complexes with biologically
active ligands to include the anti-oxidant activity of
AOA (Fig. 1), coumarin-3-carboxylic acid (CCA,
Fig. 2), and their lanthanide(III) complexes. The
intention was to investigate the lanthanide(III) effect,
bearing in mind the therapeutic importance of orotic
acid derivatives with a substituent in position 5 of
the pyrimidine nucleus and the activity of 3-substi-
tuted coumarins. Since the above mentioned impact
of concentration ratio between the tested compound
and iron is high, this study tested both types of
lanthanide(III) complexes in different concentrations
in order to analyze in detail their effects on iron-
driven production of the highly reactive hydroxyl
radical using a previously established method.2,27
Material and methods
Materials
Ferrous sulfate heptahydrate, ferric chloride, hydro-
xylamine, ferrozine, sodium acetate, acetic acid,
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), HEPES sodium salt, salicylic acid, 2,3-dihy-
droxybenzoic acid, and 2,5-dihydroxybenzoic acid
were purchased from Sigma-Aldrich Inc. (St Louis,
USA), hydrogen peroxide was from Coopharma s.r.o.
(Prague, Czech Republic), phosphoric acid was from
Lachema a.s. (Brno, Czech Republic), and dimethyl
sulfoxide (DMSO) and methanol for HPLC, super gra-
dient grade, were from Lach-Ner s.r.o (Neratovice,
Czech Republic).
Complexes
The synthesis of the lanthanide(III) complexes of
AOA and CCA as well as their theoretical, analyti-
cal, spectral, and structural characterization have
been previously reported by us.22–26,28,29 Shortly: the
compounds used for preparing the solutions were
Merck products, p.a. grade: Ce(NO3)3·6H2O,
La(NO3)3·6H2O, Nd(NO3)3·6H2O, Sm(NO3)3·6H2O,
Gd(NO3)3·6H2O, and Dy(NO3)3·5H2O. CCA and
AOA (Sigma-Aldrich) were used for the preparation
of metal complexes as ligands.
The complexes of CCAwere synthesized by reaction
of cerium(III), lanthanum(III), neodymium(III),
samarium(III), gadolinium(III), and dysprosium(III)
inorganic salts and the ligand, in amounts equal to
metal/ligand molar ratio of 1:2. The synthesis of the
complexes was achieved using different ratios (1:1,
1:2, 1:3) but in all cases the product had a composition
of 1:2. The complexes were prepared by adding
ethanol solutions of Ln(III) salts to ethanol solutions
of the ligand. The reaction mixture was stirred with
an electromagnetic stirrer at 25°C for 1 hour and at
the moment of mixing, precipitates were obtained.
These were filtered, washed several times with water
and ethanol, and dried in a desiccator to constant
weight. The complexes were insoluble in water,
partly soluble in methanol and ethanol, and soluble
in DMSO. The data from the elemental analysis of the
obtained compounds served as the basis for determining
their empirical formulae: Ce(CCA)2(NO3)·H2O,
La(CCA)2(NO3)·2H2O, Nd(CCA)2(NO3)·H2O,
Sm(CCA)2(NO3)·H2O, Gd(CCA)2(NO3)·H2O, and
Dy(CCA)2(NO3)·H2O, where CCA = C10H5O−4 .
The complexes of AOAwere synthesized by reaction
of cerium(III), lanthanum(III), and neodymium(III)
salts and the ligand, in amounts equal to a metal/Figure 2 The structure of CCA.
Figure 1 The structure of AOA.
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ligand molar ratio of 1:3. The complexes were pre-
pared by adding an aqueous solution of cerium(III),
lanthanum(III), and neodymium(III) salts to an
aqueous solution of the ligand, subsequently raising
the pH of the mixture gradually to ca. 5.0 by adding
a dilute solution of sodium hydroxide. The reaction
mixture was stirred with an electromagnetic stirrer
at 25°C for 1 hour. At the moment of mixing of the
solutions, precipitates were obtained. These were fil-
tered, washed several times with water, and dried in
a desiccator to constant weight. The complexes
were insoluble in water, partly soluble in methanol
and ethanol, and soluble in DMSO. The obtained
formula for the Ln(III) complexes of AOA are
as follows: Ce(AOA)3·3H2O, La(AOA)3·3H2O, and
Nd(AOA)3·3H2O, where AOA = C5N3O4H−4 .
Fenton chemistry experiments
This method is based on trapping hydroxyl radicals
by an indicator (salicylic acid) with the resulting
production of 2,3-dihydroxybenzoic acid and 2,5-
dihydroxybenzoic acids, which are then spectropho-
tometrically measured using HPLC.27
Sample preparation
Freshly prepared solution (200 μl) of ferrous ions in
ultrapure water (5 mM) was mixed with the same
volume of methanolic solution consisting of tested
compound (different concentrations) and salicylic
acid (25 mM). After 2 minutes of mixing, 200 μl of
hydrogen peroxide (25 mM) in ultrapure water were
added and the mixture was analyzed by HPLC.
HPLC-DAD method for analysis of hydroxyl
radical production
A Dionex Ultimate 3000 liquid chromatograph
equipped with diode array detector was used.
Spectra were recorded for all peaks in the wavelength
range of 190–750 nm.
For the separation of salicylic acid, 2,3-dihydroxy-
benzoic acid, and 2,5-dihydroxybenzoic acid, an
Eclipse Plus C18 column (4.6 × 100 mm, 3.5 μm,
Agilent, Santa Clara, CA) was used. The mobile
phase consisted of 40% methanol and 60% of
aqueous solution of phosphoric acid (0.085%) and iso-
cratic elution was carried out for 6 minutes. The flow
rate of the mobile phase was 1.2 ml/min. For quanti-
fication, six-point calibration curves were obtained
with pure standards. Identification of substances in
samples was accomplished by comparing elution
times and spectral characteristics with the standards.
All experiments were checked by addition of an
internal standard (known amounts of 2,3-dihydroxy-
benzoic and 2,5-dihydroxybenzoic acids). The results
were calculated as the mean of the sample analysis
(250 μl) (1) mixed with 50 μl methanol and (2) with
added internal standards (50 μl of methanolic solution
of 2,3-dihydroxybenzoic and 2,5-dihydroxybenzoic
acids).
Iron chelation and reduction experiments
These methods are based on a sensitive indicator for
ferrous ions – ferrozine. The complex of ferrozine
with ferrous ions is then measured at 562 nm by spec-
trophotometry. Non-chelated or reduced ferric ions
can be visualized after reduction with a suitable reduc-
tant (hydroxylamine).20
Shortly, 50 μl of AOA or CCA solutions in DMSO
in various concentrations were mixed in different
15 mM buffers (150 μl; acetate for pH 4.5 and 5.5
and HEPES for pH 6.8 and 7.5) with 50 μl of
ferrous or ferric ions (250 μM) dissolved in ultrapure
water for 2 minutes. In the case of ferric chelation,
hydroxylamine at a concentration of 10 mM was then
added to reduce non-chelated ferric to ferrous ions.
Ferrozine (50 μl, 10 mM) was then added and absor-
bance measured immediately and after 5 minutes using
the Synergy HT Multi-Detection Microplate Reader
(BioTek Instruments, Inc., Winooski, Vermont, USA).
In all experiments, the solvent (DMSO) was used as a
control. In iron reduction experiments, 10 mMof hydro-
xylamine was used as well as positive control (100% of
iron reduction).
Statistical analysis
The data on tested compounds for each ratio were ana-
lyzed using the two-way ANOVAwith Tukey multiple
comparison test. For iron reduction experiments, the
percent reduction was compared by use of t-test vs.
the blank sample with DMSO. The minimal relevant
level of significance was considered at P< 0.05.
Results are shown as means± SEM.
Results and discussion
Given that the ligands used are well-known biologi-
cally active compounds, we compared them with the
lanthanide(III) complexes which we have character-
ized.22–26,28,29 Detailed analysis of AOA and
Ln(III)–AOA systems revealed that the binding mode
in the complexes was bidentate through the carboxylic
oxygen atoms. It has been suggested that CCA binds
to Ln(III) ions through both oxygen atoms of the car-
boxylic and carbonylic groups.
All lanthanide complexes as well as the pure ligands
were tested for iron-mediated hydroxyl radical for-
mation (the Fenton reaction). All tested compounds
had neutral or positive effect on this reaction: no com-
pound behaved as a pro-oxidant in any of the concen-
trations tested. However, there were marked
differences between compounds related to their anti-
oxidant activity. In general, two types of behavior
were observed: (a) progressively anti-oxidant, i.e.
with increasing ratio of the tested compound to iron,
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inhibition of the Fenton reaction increased or (b) bell-
shaped, i.e. inhibition of the Fenton reaction was
observed in lower ratios but at higher ratios, the
effect was neutral.
Both ligands alone had slight anti-oxidant effects
but at much higher concentrations than their com-
plexes. In the case of AOA, the anti-oxidant effect
was apparent in the ratio 2:1, AOA to Fe2+, respect-
ively, while in the case of CCA from the ratio 1:1
(Fig. 3A). These differences aside, the curves were
different only at the ratio 0.5 (1:2, ligand to the
Fe2+, respectively). Since their effects on Fenton
chemistry were quite small, we tested the interaction
of both ligands with iron. In line with their low
effect on Fenton chemistry, CCA did not significantly
chelate or reduce iron at any of the tested conditions
(data not shown), while AOA chelated only ferric but
not ferrous iron at pH 4.5 (Fig. 4A). However, its che-
lation activity was low, expressed particularly in higher
ratios, and markedly dropped after 5 minutes,
suggesting that the complex of AOA with Fe3+ is not
very stable. Similarly, AOA reduced iron but this
reduction was low, reaching a maximum of 4–20% of
reduced iron at the ratio 100:1, AOA/Fe respectively,
depending on pH (Fig. 4B). These data reporting
only modest or no interaction of ligands with iron
suggest that the mild inhibitory effects of both
ligands on Fenton chemistry are caused by their
direct interaction with the hydroxyl radical (direct
anti-oxidant effect).
In the case of AOA complexes, both types of beha-
viors described in relation to Fenton chemistry were
observed (Fig. 3B). The neodymium complex was
very active at low ratios. Compared to the ligand,
AOA at ratios 1:20 (i.e. 0.05) and 1:10 (0.1), the
neodymium–AOA–complex was significantly more
active (P< 0.001). The cerium complex in the ratio
1:10 (P< 0.05) was also more active than AOA while
the lanthanum complex was not significantly active
in this ratio. On the other hand, both cerium and neo-
dymium complexes corresponded to bell-shaped
curves and their anti-oxidant activity disappeared
with increasing concentrations while lanthanum
complex behaved as progressive anti-oxidant and
whose activity was apparent and progressive from
the ratio of 1:4.
In the case of lanthanide complexes with CCA, the
results were analogous but the activity was lower than
the corresponding lanthanide–AOA–complex. This
signifies that again, neodymium-formed complexes
were clearly active at low ratios (ratios 1:50 and 1:20,
P< 0.01 vs. CCA, Fig. 3C) but similarly active to
the ligand CCA at higher ratios while the lanthanum
complex was again progressively anti-oxidant and its
anti-oxidant effect occurred as well from the ratio of
1:4. The only exception was the cerium complex,
which was almost inactive. Of the other tested
complexes, of particular note was the samarium
complex with CCA (Fig. 3D) which was active
from the ratio of 1:20 to 1:4 (P< 0.05). The
gadolinium–CCA–complex formed bell-shaped
curves (active at the ratio of 1:10, P< 0.05) too. The
dysprosium complex was inactive at low ratios but sig-
nificant although mild activity was observed at the
ratio of 1:2 (P< 0.001).
Certainly the involvement of the lanthanides in ROS
removal is quite different from the inhibition of ROS
by organic compounds. Most organic anti-oxidants
scavenge free radicals by single electron exchange
with radicals, thus transforming themselves into rad-
icals and hence act as ‘pro-oxidants’ even in the
absence of a free transient metal. A lanthanide(III)
very easily interacts with either free radicals or per-
oxides but it is not transformed into a radical.
However, mechanistic understanding of the role of
lanthanide(III) as a scavenger of reactive oxidative
species is very scanty. The lability of lanthanide com-
plexes, strong oxyphilicity, rapid water exchange reac-
tions, the non-directionality of lanthanide ligand
bonds, and varying coordination numbers, all contrib-
ute to lanthanide interaction with biomolecules. The
ionic size of lanthanide(III) varies from one to
another lanthanide. In addition, the ionic size of a par-
ticular lanthanide also varies significantly with the
respective coordination number. This can explain the
different coordinating potential as well as different
biological behavior of the respective lanthanides
under different pathophysiological conditions. The
importance of concentration/ratio of tested com-
pound to metal is crucial (e.g. Fig. 3), as it is for
other anti-oxidants. In our preliminary analysis of
only one concentration, there was a small difference
between the acute effects of the AOA and its
complexes.26
There are two major issues coming from the study.
Firstly, as expected, lanthanide(III) complexes alone
did not potentiate the Fenton chemistry but blocked
it or had neutral effect depending on lanthanide
present in the complex. This may be an important
factor compared to classical anti-oxidants. As far we
know, the most potent inhibitor of the Fenton chem-
istry in low concentrations is the flavonoid taxifolin
which is very efficient in extremely low ratios of flavo-
noid to iron (1:1000) but in approaching the ratio 1:1,
its activity ceases.2 In this study, the tested complexes
of neodymium and gadolinium and partly as well
that of cerium behaved similarly but their potency
was lower and the maximum activity was observed
approximately in the ratio of 1:20. This feature may
limit their use in practice. Lanthanum complexes are
of much greater interest, since they inhibited the
Fenton reaction in a concentration-dependent
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manner. For comparison, such desired activity has
only been observed in some non-chelating flavonoids
or strong iron chelators such as deferoxamine.2
Secondly, the resulting effect on Fenton chemistry
depended on the lanthanide(III) element in particular,
as can be seen from Fig. 3. However, the potency can
be clearly modulated by selection of ligand. This is of
particular interest, since some of these complexes may
be unstable in plasma.26 In solution as in this study,
the complexes, at least in low ratios, were likely
stable as their activity was different from and higher
than pure ligands in most cases. However, it is possible
that some lanthanide(III) complexes which have bell-
shaped effects on Fenton chemistry are less stable in
higher ratios and therefore their curves approach
those of the ligands. The serious drawback for
testing the complexes is their low solubility in the reac-
tion medium. It would be of interest in future studies
to analyze ratios in which the complex is in much
higher concentrations than iron. This will necessitate
other method with higher sensitivity which will
enable to decrease the concentration of both the iron
and the complex.
In conclusion, this study extends our previous
results showing preliminary anti-oxidant effects of
lanthanide complexes of AOA. The results show that
(1) lanthanide(III) complexes with both AOA and
CCA had positive or neutral effect on hydroxyl
radical production by Fenton chemistry and (2) the
lanthanide(III) element seems to be crucial for the
anti-oxidant effect.
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